Global Urology Disposables Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Urology Disposables Market Size

• The global urology disposables market size was valued at USD 4.21 billion in 2024 and is expected to reach USD 6.82 billion by 2032, at a CAGR of 6.20% during the forecast period
• The market growth is largely fueled by the rising incidence of urological disorders such as urinary incontinence, kidney stones, and benign prostatic hyperplasia, along with the aging global population—particularly in developed and emerging economies
• Furthermore, increased healthcare expenditure, a growing preference for minimally invasive treatments, and the expanding use of disposable medical products to reduce hospital-acquired infections are driving the demand for urology disposables. These converging factors are accelerating the adoption of disposable urological products in both hospital and homecare settings, thereby significantly boosting the industry's growth

Urology Disposables Market Analysis

• Urology disposables, encompassing a wide range of single-use medical devices such as catheters, drainage bags, stents, and irrigation sets, are increasingly vital components of urological care due to their role in reducing hospital-acquired infections, enhancing procedural efficiency, and improving patient comfort in both acute and chronic urological conditions
• The escalating demand for urology disposables is primarily fueled by the rising prevalence of urinary disorders, increasing geriatric population, and growing preference for minimally invasive treatments, coupled with the need for cost-effective, hygienic, and patient-friendly urological solutions
• North America dominates the urology disposables market with the largest revenue share of 40.5% in 2024, characterized by a well-established healthcare infrastructure, high awareness of urological health, and widespread adoption of disposable medical products
• Asia-Pacific is expected to be the fastest growing region in the urology disposables market during the forecast period due to increasing healthcare investment, improving access to medical care, and a rising elderly population prone to urological issues
• Urine Catheters segment dominates the urology disposables market with a market share of 42.5% in 2024, driven by its essential use in post-operative care, critical care units, and long-term management of urinary retention and incontinence, along with a wide range of product variants catering to different clinical needs

Report Scope and Urology Disposables Market Segmentation

Urology Disposables Market Trends

“Enhanced Safety and Patient Comfort Through Advanced Coatings and Design”

• A significant and accelerating trend in the global urology disposables market is the widespread adoption of antimicrobial coatings and hydrophilic materials in products such as catheters and urine collection bags. These innovations aim to minimize the risk of catheter-associated urinary tract infections and improve patient comfort during use
  • For instance, industry leaders such as Coloplast and Becton Dickinson have developed coated catheters that reduce friction, inhibit bacterial growth, and enhance ease of insertion. In addition, self-catheterization kits designed for home use are increasingly popular, enabling patients to manage their urological conditions safely and independently
• The shift from reusable to single-use sterile disposables is gaining traction due to stringent infection control protocols, particularly amplified by the COVID-19 pandemic. This move not only reduces cross-contamination risks but also aligns with evolving regulatory standards in healthcare
• Moreover, there is growing demand for urology disposables specifically optimized for homecare settings, where safety, discretion, and ease of use are crucial. Products such as male external catheters and advanced drainage systems cater to patients with chronic urological issues who prefer home management over hospital visits
• This comprehensive focus on infection control, patient comfort, and technological advancement is driving innovation and expanding the global urology disposables market, reshaping user expectations in both clinical and homecare environments

Urology Disposables Market Dynamics

Driver

“Rising Incidence of Urological Disorders and Growing Focus on Infection Control”

• The increasing prevalence of urological disorders such as urinary incontinence, urinary retention, and chronic kidney disease is a significant driver for the growing demand for urology disposables worldwide
  • For instance, in early 2024, Coloplast introduced a new line of antimicrobial-coated catheters designed to reduce infection risks and enhance patient comfort. Innovations such as these by key market players are expected to propel the urology disposables market during the forecast period
• As healthcare providers become more aware of catheter-associated urinary tract infections (CAUTIs) and implement stricter infection control protocols, the adoption of single-use, sterile urology disposables is accelerating
• Furthermore, the rising preference for homecare management of chronic urological conditions is boosting demand for disposable products such as self-catheterization kits and urine collection bags, providing patients with convenience and safety outside hospital settings
• The ease of use, enhanced safety features, and patient-centric designs are critical factors driving adoption across hospitals, specialty clinics, and homecare environments. In addition, improving healthcare infrastructure and favorable reimbursement policies globally are further supporting market growth

Restraint/Challenge

“Concerns Regarding Infection Risks and High Treatment Costs”

• Concerns surrounding the risk of catheter-associated urinary tract infections (CAUTIs) and other healthcare-associated infections pose significant challenges to broader adoption of urology disposables. Despite advances in antimicrobial coatings and sterile packaging, the fear of infection continues to impact user confidence and healthcare provider preferences
  • For instance, reports of infections linked to improper catheter use or reuse of disposable products have made some hospitals and patients hesitant to fully embrace certain urology disposables without rigorous training and monitoring
• Addressing these infection control concerns through improved product designs, strict adherence to hygiene protocols, and comprehensive patient education is crucial for building trust. Companies such as Coloplast and Becton Dickinson emphasize their antimicrobial technologies and sterile manufacturing processes in marketing to reassure healthcare providers and patients. In addition, the relatively high cost of advanced disposable urology products compared to reusable alternatives can be a barrier to adoption, particularly in developing regions or for budget-constrained healthcare facilities
• While prices for basic catheters and disposables remain affordable, premium features such as antimicrobial coatings and smart monitoring systems often come with a higher price tag
• Overcoming these challenges through continued innovation, cost reduction strategies, and enhanced training on product use and infection prevention will be vital for sustained market growth

Urology Disposables Market Scope

The market is segmented on the basis of product type and end user.

• By Product Type

On the basis of product type, the global urology disposables market is segmented into urine catheters, urine collection bags, male external catheters, stents, drainage sets, and others. The urine catheter segment dominates the market with the largest revenue share of 42.5% in 2024, driven by the high prevalence of urinary tract disorders and widespread clinical use in hospitals and homecare settings. Catheters with advanced antimicrobial coatings and hydrophilic surfaces are increasingly preferred to reduce infection risks and enhance patient comfort, further boosting segment growth.

The urine collection bags segment is expected to witness fastest CAGR during forecast period, supported by their essential role in fluid management during catheterization procedures and increasing adoption in intensive care units and homecare environments. Other product types such as male external catheters and stents are witnessing steady growth due to rising awareness of non-invasive urological management and technological advancements improving user convenience and safety.

• By End User

On the basis of end user, the global urology disposables market is segmented into hospitals, intensive care units (ICUs), surgical centers, specialty clinics, and homecare settings. Hospitals held the largest market revenue share in 2024, driven by the extensive use of urology disposables in inpatient care, surgeries, and emergency procedures.

Homecare settings are anticipated to register the fastest growth during the forecast period, propelled by the increasing trend of outpatient management for chronic urological conditions and the growing preference for self-catheterization and home-based urine management. Specialty clinics and surgical centers also contribute to market expansion through rising outpatient procedures and minimally invasive urology treatments.

Urology Disposables Market Regional Analysis

• North America dominates the urology disposables market with the largest revenue share of 40.5% in 2024, driven by a well-established healthcare infrastructure, high awareness of urological health, and widespread adoption of disposable medical products
• Healthcare providers and patients in the region prioritize infection control and patient safety, fueling demand for single-use catheters, antimicrobial-coated devices, and other innovative urology disposables
• This widespread adoption is further supported by favorable reimbursement policies, growing awareness about catheter-associated urinary tract infections (CAUTIs), and the presence of major market players investing in research and development to launch improved products

U.S. Urology Disposables Market Insight

The U.S. urology disposables market captured the largest revenue share within North America in 2024, driven by a high prevalence of urological disorders and well-established healthcare infrastructure. The rapid adoption of advanced disposable products, including antimicrobial-coated catheters and single-use urine collection systems, is fueling market growth. Increasing awareness about infection control and stringent hospital protocols further boost demand. The rising trend of homecare management for chronic urological conditions, supported by patient education and reimbursement policies, is expanding usage beyond hospitals into outpatient and homecare settings.

Europe Urology Disposables Market Insight

The Europe urology disposables market is projected to grow steadily throughout the forecast period, primarily driven by increasing healthcare expenditure, aging populations, and growing incidence of urological diseases. Strict regulatory guidelines focusing on infection prevention and patient safety are propelling adoption of sterile, single-use urology products. Urbanization and rising demand for outpatient urological treatments are supporting growth in specialty clinics and surgical centers. The market also benefits from continuous technological advancements and increasing integration of disposables in minimally invasive procedures.

U.K. Urology Disposables Market Insight

The U.K. urology disposables market is anticipated to expand at a notable CAGR during the forecast period, fueled by rising cases of urinary incontinence and urinary tract infections (UTIs). Government initiatives promoting preventive healthcare and increased patient awareness are encouraging the use of disposables in hospitals and homecare. The growing emphasis on reducing healthcare-associated infections and improving quality of care is driving demand for innovative and easy-to-use catheterization products.

Germany Urology Disposables Market Insight

The Germany urology disposables market is expected to witness significant growth, supported by a robust healthcare system and high standards for infection control. Increasing focus on patient safety and quality healthcare services drives adoption of sterile, single-use urology disposables in hospitals and ICUs. Germany’s emphasis on sustainability is also encouraging development and use of eco-friendly disposable products. Growing outpatient procedures and demand for advanced urological care in commercial clinics further contribute to market expansion.

Asia-Pacific Urology Disposables Market Insight

The Asia-Pacific urology disposables market is poised for the fastest growth during the forecast period, driven by rapid urbanization, improving healthcare infrastructure, and increasing prevalence of urological diseases in countries such as China, India, and Japan. Government initiatives to improve healthcare access and awareness, combined with rising disposable incomes and expanding insurance coverage, are accelerating adoption. The growing trend towards home-based care and self-catheterization is significantly expanding the market in the region.

Japan Urology Disposables Market Insight

The Japan urology disposables market is gaining momentum due to the country’s aging population and increasing incidence of urological disorders. High healthcare standards and advanced medical technology adoption support strong demand for innovative disposable products that reduce infection risks and improve patient comfort. The integration of disposables with advanced monitoring systems and homecare solutions is contributing to growth in both residential and hospital settings.

India Urology Disposables Market Insight

The India urology disposables market accounted for the largest revenue share in Asia-Pacific in 2024, fueled by a rapidly growing middle class, increasing awareness of urological health, and expanding healthcare infrastructure. The push towards affordable healthcare and government initiatives for rural health improvements are driving adoption in both urban and semi-urban areas. The rising prevalence of urinary disorders and a growing preference for disposable, easy-to-use products in homecare and hospitals further propel the market.

Urology Disposables Market Share

The urology disposables industry is primarily led by well-established companies, including:

• Boston Scientific Corporation (U.S.)
• B. Braun SE (Germany)
• Coloplast A/S (Denmark)
• Teleflex Incorporated (U.S.)
• Cook (U.S.)
• Medtronic (Ireland)
• BD (U.S.)
• Hollister Incorporated (U.S.)
• ConvaTec Group PLC (U.K.)
• Laborie (U.S.)
• Dentsply Sirona (U.S.)
• UROMED Kurt Drews KG (Germany)
• Romsons Scientific & Surgical Pvt. Ltd. (India)
• Manfred Sauer GmbH (Germany)
• Amsino International, Inc. (U.S.)
• Medline Industries, Inc. (U.S.)
• Cathetrix (Israel)
• Dover (Israel)
• Stryker (U.S.)
• L'ISOLANTE K-FLEX SpA (Italy)

Latest Developments in Global Urology Disposables Market

• In October 2024, Teleflex Incorporated launched the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada. These devices are designed to enhance peripherally inserted central catheter (PICC) insertion procedures, providing real-time catheter tip location information and improved navigation, reducing complications
• In May 2024, Graminex L.L.C. announced the completion of a clinical trial investigating the efficacy of its flower pollen extract products, Graminex RCT Fem UI and Graminex PollenBerry, in treating urinary incontinence in women. The study demonstrated significant improvements in urinary incontinence severity and related symptoms
• In May 2024, Graminex L.L.C. announced the publication of a peer-reviewed clinical study in the journal Current Urology. The study focused on the use of Graminex Flower Pollen Extract for women's urinary incontinence and urinary health, providing scientific validation for the product's efficacy
• In October 2023, Ambu A/S obtained European regulatory clearance (CE mark) for its Ambu aScope 5 Cysto HD, a single-use cystoscope integrated with the Ambu aView 2 Advance endoscopy system. This product offers urologists advanced imaging capabilities, contributing to improved diagnostic accuracy and patient care
• In August 2023, Fresenius Medical Care announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its NxStage VersiHD with GuideMe Software, a chronic home hemodialysis system. The new system aims to enhance patient and nurse experience through a self-guided interface, improving ease of use and confidence

SKU-74156